Pathogenic variants of <i>FOXP2</i> gene were identified first as a monogenic cause of childhood apraxia of speech (CAS), a complex disease that is associated with an impairment of the precision and consistency of movements underlying speech, due to deficits in speech motor planning and programming. This evidence concerns the gene FOXP2 and childhood apraxia of speech.